GARADACIMAB (Andembry®)
Clinical Indication
Preventing recurrent attacks of hereditary angioedema in people 12 years and over
Date of classification
November 2025
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.